Jefferies and Cowen are bookrunners; Oppenheimer, Roth Capital assist
By Devika Patel
Knoxville, Tenn., Nov. 14 – NeuroDerm Ltd. said it priced its $45 million initial public offering of stock with a $6.75 million greenshoe. The deal was announced on Sept. 15.
The company will sell 4.5 million ordinary shares at $10.00 per share.
Jefferies LLC and Cowen and Co., LLC are the bookrunning managers.
Settlement is expected on Nov. 19.
Proceeds will be used for product development, research, working capital and for general corporate purposes.
The clinical-stage pharmaceutical company is based in Rehovot, Israel. It intends to list its stock on the Nasdaq under the symbol “NDRM.”
| Issuer: | NeuroDerm Ltd.
|
| Issue: | Ordinary stock
|
| Amount: | $45 million
|
| Greenshoe: | $6.75 million
|
| Shares: | 4.5 million
|
| Price: | $10.00
|
| Warrants: | No
|
| Bookrunners: | Jefferies LLC and Cowen and Co,, LLC
|
| Co-managers: | Oppenheimer & Co. and Roth Capital Partners
|
| Announcement date: | Sept. 15
|
| Pricing date: | Nov. 14
|
| Settlement date: | Nov. 19
|
| Stock exchange: | Nasdaq: NDRM
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
